FENC: Evans Terry L reports a stock award
By AlphaYouPublished Form 4
Evans Terry L
Reporting filer
Evans Terry L reports a stock award, not an open-market purchase or sale, in Fennec Pharmaceuticals Inc.. Form 4 filed Oct 13, 2026 lists 1 entry.
- Disclosed
- Oct 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Evans Terry L | 2026-10-12 | A | Grant or award | 2326 | 5.53 | 24,013 | 1 day | Filed terms
|
Common Shares
- Owner
- Evans Terry L
- Date
- 2026-10-12
- Code
- A
- Action
- Grant or award
- Quantity
- 2326
- Price
- 5.53
- Following holdings
- 24,013
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Shares
- id: F1
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 2326
- transaction Price Per Share: 5.53
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 24013
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Evans Terry L: Chief Commercial Officer.
- F1: The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of April 9, 2026 through October 12, 2026.
- F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.